$50,000 Awarded To Barrow Neurological Institute Neuroimmunology Post-doctoral Fellow, To Support Her Research Of Treatment For Multiple Sclerosis
Main Category: Multiple SclerosisArticle Date: 17 Feb 2006 - 6:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Young-Huen Jee, Ph.D., a post-doctoral fellow at Barrow Neurological Institute in Phoenix, recently received a $50,000 fellowship award from the Hob Family Foundation to support her research of treatment for Multiple Sclerosis (MS).
Dr. Jee's research focuses on action mechanisms of the MS drug Copaxone in Experimental Autoimmune Encephalomyelitis (EAE), a form of MS. When she joined Barrow's Neuroimmunology Laboratory in March 2005, Dr. Jee began testing the effect of Copaxone in mice without specialized immune system proteins that help eliminate disease. Surprisingly, she found that the drug protected them from becoming afflicted with EAE.
Her discovery challenged the prevailing view of the way Copaxone functions and prompted her to investigate alternative mechanisms of the drug's action. Dr. Jee's initial findings received enthusiastic comments from International Immunology and have been accepted for publication in this prestigious journal. Her current results suggest that Copaxone's ability to prevent EAE occurs largely through its effect on regulatory T cells, which are specialized cells of the immune system.
"In a very short time, Dr. Jee has uncovered a previously unrecognized mechanism underlying several important routes through which the immune system can modulate MS, an incapacitating disease of humans," says Timothy Vollmer, M.D., chairman of Barrow's Neurology Department. "Her discoveries will pave the way for novel therapies based on targeting NKT cells to control disease."
###
Contact: Jennifer Kennedy
jennifer.kennedy@chw.edu
St. Joseph's Hospital and Medical Center
Visit our multiple sclerosis section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/37698.php>
APA
http://www.medicalnewstoday.com/releases/37698.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



